Literature DB >> 4056755

Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre-S region of the hepatitis B virus (HBV) envelope gene.

A R Neurath, S B Kent, N Strick, D Stark, P Sproul.   

Abstract

Proteins of the HBV envelope (env) are coded for by two adjacent regions of the HBV env gene: the pre-S and S regions. Antigenic determinants corresponding to amino acid sequences of both regions are recognized by human antibodies and are important in virus-neutralizing responses. Protective immune responses to HBV appear to be linked to the major HLA histocompatibility complex. Inbred and congenic strains of mice represent a model system relevant for studies on the genetic control of immune responsiveness of humans to HBV envelope proteins. Such mouse strains were ranked according to their antibody response to the S protein and divided into high [d,q], intermediate [a,k,b], and low [s] responders (letters in brackets indicate H-2 haplotype.) Selected pre-S antigenic determinants can be mimicked with high fidelity by synthetic peptide analogues that are immunogenic without any carriers. Thus it is possible to study directly the genetic control of immune responsiveness to pre-S epitopes mimicked by these peptides without having to consider the influence of carriers or of S protein. The results presented here show that inbred mouse strains can be ranked according to their antibody responses to the synthetic peptide pre-S(120-145) as follows: A/J[a] approximately equal to SWR/J[q] greater than C57BL/6J[b] approximately equal to AKR/J[k] approximately equal to SJL/J[s] much greater than DBA/2J[d] greater than BALB/cJ[d]. Only SJL/J[s] mice responded well to another synthetic peptide pre-S (12-32). Thus, H-2-linked genes regulating the immune response to S protein and to epitopes on pre-S-coded sequences are distinct. Anti-pre-S(120-145) responses in S protein-nonresponders circumvent this nonresponsiveness. This should be considered in the design of hepatitis B vaccines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056755     DOI: 10.1002/jmv.1890170204

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.

Authors:  Wei-Guo Hu; Jun Wei; Heng-Chuan Xia; Xin-Xiu Yang; Feng Li; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

2.  The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.

Authors:  P J Wismans; J van Hattum; G C De Gast; H J Endeman; J Poel; B Stolk; T Maikoe; G C Mudde
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

3.  Distinctive properties of the hepatitis B virus envelope proteins.

Authors:  K L Molnar-Kimber; V Jarocki-Witek; S K Dheer; S K Vernon; A J Conley; A R Davis; P P Hung
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus.

Authors:  J A Nicholas; M A Mitchell; M E Levely; K L Rubino; J H Kinner; N K Harn; C W Smith
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.

Authors:  C Ferrari; A Bertoletti; A Penna; A Cavalli; A Valli; G Missale; M Pilli; P Fowler; T Giuberti; F V Chisari
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.

Authors:  H J Schlicht; C Kuhn; B Guhr; R J Mattaliano; H Schaller
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection.

Authors:  Masataka Tsuge; Nobuhiko Hiraga; Takuro Uchida; Hiromi Kan; Eisuke Miyaki; Keiichi Masaki; Atsushi Ono; Takashi Nakahara; Hiromi Abe-Chayama; Yizhou Zhang; Makokha Grace Naswa; Tomokazu Kawaoka; Daiki Miki; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Hidenori Ochi; C Nelson Hayes; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2016-03-04       Impact factor: 7.527

8.  In vitro immune responses to hepatitis B surface antigen (Pre-S2 and S) following remote infection by hepatitis B virus in humans.

Authors:  T R Cupps; J H Hoofnagle; R W Ellis; W J Miller; L Seeff; A Guerrera; J L Gerin; S A Haas-Smith
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

9.  The development of novel hepatitis B vaccines.

Authors:  A J Zuckerman
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

10.  The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

Authors:  C Ferrari; A Penna; A Bertoletti; A Cavalli; A Valli; C Schianchi; F Fiaccadori
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.